Prognostic Value of Transcranial Doppler Ultrasound in the Clinical Evolution of Patients With Acute Ischemic Stroke. The TRADE-AIS Study

ConditionStroke
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJose Ivan Rodriguez de Molina Serrano

About this trial

This prospective observational study aims to determine whether specific parameters measured by transcranial Doppler ultrasound (TCD) can predict clinical outcomes in patients with acute ischemic stroke (AIS). The primary objective is to evaluate the association between middle cerebral artery (MCA) flow velocities and short-term neurological improvement. Secondary outcomes include the presence of collateral flow and flow patterns in relation to functional recovery measured by NIHSS and modified Rankin Scale (mRS) scores.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Clinical diagnosis of acute ischemic stroke

Onset of symptoms ≤ 24 hours before admission

Underwent or will undergo transcranial Doppler ultrasound within 24 hours of symptom onset

Disqualifiers

Evidence of intracerebral hemorrhage on imaging

Inadequate temporal acoustic window for transcranial Doppler

Intubated or hemodynamically unstable prior to Doppler evaluation

Known diagnosis of neurodegenerative disease significantly affecting baseline neurological function (e.g., advanced dementia, Parkinson's disease)

Trial design

Treatments tested in this trial

  • Transcranial Doppler Ultrasound

Treatment groups

50 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

Jose Ivan Rodriguez de Molina Serrano

Lead sponsor

Clinica Mexico

Sponsor institution